Results 101 to 110 of about 1,217 (189)

MS [PDF]

open access: yes, 2007
thesisThis study developed a general model for the calculation of drug therapy costs for the cost comparison of two or more therapeutically equivalent drugs. In order in identify all the cost of drug therapy, the drug use process was extensively studies
Knigge, Katia Pei-Wei Tung
core  

Russian Study on Optimal Blood Pressure Reduction (ROSA 2). Two-year follow-up. What is the result?

open access: yesКардиоваскулярная терапия и профилактика, 2005
Twenty centers from 19 Russian regions took part in ROSA 2, following the first ROSA study. Aim. In arterial hypertension (AH) patients, to compare efficacy, safety, and impact on cardiovascular event (CVE) incidence for two treatment strategies ...
Yu. N. Belenkov   +2 more
doaj  

Comparison of cyclothiazide and hydrochlorthiazide in hypertension. Effects of different doses of diuretics.

open access: yesCor et vasa, 1986
In a group of 12 hypertensive outpatients, randomized double-blind cross-over comparison of the antihypertensive effect of various doses of cyclothiazide and hydrochlorthiazide revealed that 2.5 mg of cyclothiazide daily or 25 mg of hydrochlorthiazide daily have an equal antihypertensive effect.
A J, Jounela, H, Juustila, M, Lilja
openaire   +1 more source

Current use of thiazide diuretics and prevention of femur fractures [PDF]

open access: yes, 1996
Bakker, A. (Albert)   +5 more
core   +1 more source

Physical Activity and Risk of Frailty in U.S. Women 60 Yr and Older. [PDF]

open access: yesMed Sci Sports Exerc, 2023
Fung TT   +5 more
europepmc   +1 more source

SIMULTANEOUS ESTIMATION OF IRBESARTAN AND HYDROCHLOROTHIAZIDE BY UV SPECTROSCOPY [PDF]

open access: yes, 2015
Objective: The literature survey revealed that various methods are reported for determination of Irbesartan and Hydrochlorothiazide alone or in combination with other drugs So, the main objective of our study was to develop simple, accurate and ...
Gajbhiye, Asmita   +3 more
core  

AN ELEVATED PULSE PRESSURE: A MAJOR RISK FACTOR FOR CARDIOVASCULAR DISEASES [PDF]

open access: yes, 2013
Pulse pressure (PP) is a predictor and major risk factor for cardiovascular (CV) diseases as left ventricular hypertrophy, myocardial infarction, carotid hypertrophy, atherosclerosis, congestive heart failure and stroke as well as chronic renal failure ...
Bodakhe, Surendra H, Gupta, Sanjay K
core   +1 more source

Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics. [PDF]

open access: yesPharmaceuticals (Basel), 2022
Zuccari G   +5 more
europepmc   +1 more source

Study of Drug Use in Essential Hypertension and Their Compliance [PDF]

open access: yes, 2006
Hypertension (HTN) Affects Approximately 1 Billion People Worldwide. The Prevalence of HTN Increase with Age and Even Further Unless Broad and Effective Preventive Measures Are Implemented.
Joshi, Mili, Khan, G.M., Rao, B.S.
core   +1 more source

Home - About - Disclaimer - Privacy